Stay updated on Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Sign up to get notified when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Update to operating-status notice, new future dates and a newer revision/version; removal of older dates and older Last Update/Revision markers. Overall, signals a status refresh rather than a substantive content overhaul.
    Difference
    4%
    Check dated 2025-10-02T01:34:01.000Z thumbnail image
  4. Check
    17 days ago
    Change Detected
    Summary
    Updates to date/version metadata (e.g., Last Update, Revision), with new dates and a newer revision number indicating a version increment; removal of older date/version references.
    Difference
    1%
    Check dated 2025-09-30T13:15:17.000Z thumbnail image
  5. Check
    24 days ago
    Change Detected
    Summary
    Removed a set of MedlinePlus health topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), decreasing coverage of core medical and safety content.
    Difference
    0.4%
    Check dated 2025-09-23T09:46:36.000Z thumbnail image
  6. Check
    32 days ago
    Change Detected
    Summary
    Page version updated from v3.0.1 to v3.0.2; 'Back to Top' link removed.
    Difference
    0.2%
    Check dated 2025-09-16T04:49:14.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-09T00:34:19.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names, locations, and a significant addition of related topics, including drug safety and counterfeit drugs, while removing some previous location details and references to systemic mastocytosis.
    Difference
    6%
    Check dated 2025-09-01T20:42:46.000Z thumbnail image

Stay in the know with updates to Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Placebo in Indolent Systemic Mastocytosis Clinical Trial page.